Alaunos Therapeutics, Inc. (TCRT) NASDAQ
2.93
-0.02(-0.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.93
-0.02(-0.68%)
Currency In USD
| Previous Close | 2.95 |
| Open | 3.05 |
| Day High | 3.07 |
| Day Low | 2.9 |
| 52-Week High | 6.2 |
| 52-Week Low | 1.67 |
| Volume | 16,861 |
| Average Volume | 19,967 |
| Market Cap | 6.54M |
| PE | -1.27 |
| EPS | -2.3 |
| Moving Average 50 Days | 2.97 |
| Moving Average 200 Days | 3.09 |
| Change | -0.02 |
Data not available
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
GlobeNewswire Inc.
Mar 02, 2026 11:30 AM GMT
The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also demonstrated reductions in liver weight and improvements in select biomarkers associated with liver injur